Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
07/2003
07/30/2003CN1433411A Chemical compounds
07/30/2003CN1433396A Pharmaceutical compounds
07/30/2003CN1116291C Substituted tetracyclic tetrahydrofuran derivatives
07/29/2003US6599918 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benzopyrans
07/29/2003US6599908 Fused polycyclic 2-aminopyrimidine derivatives
07/24/2003WO2003059913A1 Roh-kinase inhibitors
07/24/2003WO2003059912A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents
07/24/2003WO2003059892A1 Substituted alkyl uracils and the use thereof
07/24/2003WO2003059356A2 Novel anti-infectives
07/24/2003WO2003059346A1 Beta-secretase inhibitors
07/24/2003WO2002078633A3 Agent for the treatment of bladder irritative symptoms accompanied by benign prostatic hyperplasia
07/24/2003WO2002078523A3 Agent for the treatment of overactive bladder
07/24/2003US20030139505 Process for the preparation of neutral polyethylenedioxythiophene, and corresponding polyethylenedioxythiophenes
07/24/2003US20030139462 Antiinflammatory agents; autoimmune disease; antiarthritic agents
07/24/2003US20030139397 Pesticides
07/24/2003US20030137240 Di(het)arylaminothiophene derivatives
07/24/2003US20030136964 Thin film transistors using solution processed pentacene precursor as organic semiconductor
07/24/2003CA2473441A1 Beta-secretase inhibitors
07/24/2003CA2473362A1 Substituted alkyl uracils and the use thereof
07/24/2003CA2472993A1 Oxothieno (3, 2-b) pyridinecarboxamides as antiviral agents
07/24/2003CA2472619A1 Fused pyrimidine derivates as rho-kinase inhibitors
07/23/2003EP1329454A1 Thienopyrimidine compounds and their salts and process for preparation of both
07/23/2003EP1329453A1 Method for obtaining 4-(n-alkylamine)-5, 6-dihydro-4h-thieno-(2,3-b)-thiopyran-2-sulfamide-7, 7-dioxides and intermediate products
07/23/2003CN1431904A Protease inhitors
07/23/2003CN1431212A Similar of sulph DCK, its synthesizing method and applications
07/22/2003US6596873 2-and 2,5-substituted phenylketoenols
07/22/2003US6596863 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis
07/22/2003US6596727 Substituted pyrimidines, processes for their preparation, and their use as pesticides and fungicides
07/22/2003US6596726 Method of inhibiting epidermal growth factor by treating, with an effective inhibiting amount, a mammal, in need thereof inhibit the epidermal growth factor receptor and related receptors and, in particular, their tyrosine kinase enzyme
07/22/2003US6596481 Dual markers
07/17/2003WO2003057173A2 Broad spectrum inhibitors
07/17/2003WO2003057161A2 BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF
07/17/2003WO2003057149A2 4-substituted fused heteropyrimidines and fused hetero-4-pyrimidones
07/17/2003US20030134872 2-acetoxy-5-(alpha-cyclopropylcarbonyl-O-fluorobenzyl)--4,5,6,7 -tetrahydrothieno(3,2-c)-pyridine, particularly the hydrochloride and the maleate
07/17/2003US20030134867 Preventing extracellular release
07/17/2003US20030134863 Preventives/remedies for alzheimer's disease
07/17/2003US20030134840 Novel compounds
07/17/2003CA2472580A1 Broad spectrum inhibitors
07/16/2003EP1327645A1 Process for the production of neutral poly(ethylenedioxythiophene) and related poly(ethylenedioxythiophenes)
07/16/2003EP1327636A2 Heterocyclic metallocenes and polymerisation catalysts
07/16/2003EP1327631A2 Fused heterocyclic compounds, their production and use as angiotensin II antagonists
07/16/2003EP1326875A2 Tumor proliferation inhibitors
07/16/2003EP1326841A1 Pyridinone derivatives for treatment of atherosclerosis
07/16/2003EP1326822A2 Ketone compounds and compositions for cholesterol management and related uses
07/16/2003EP1326619A2 Pyrrolidine modulators of ccr5 chemokine receptor activity
07/16/2003EP1165555B1 Aryl fused 2,4-disubstituted pyridines: nk3 receptor ligands
07/16/2003EP1070069B1 Bicyclic hydroxamic acid derivatives
07/15/2003US6593344 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases
07/15/2003US6593335 Disease than can be ameliorated with a potassium channel opener in a host mammal, comprising administering to the mammal in need thereof a therapeutically effective amount of the compound of claim 1; said disease is epilepsy, Raynaud's
07/14/2003WO2003059878A2 Thieno (3, 2-b) pyridones as antiviral compounds
07/14/2003CA2472960A1 Thieno (3, 2-b) pyridones as antiviral compounds
07/10/2003WO2003055890A1 Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
07/10/2003WO2003055889A1 Process for preparing a heteroaromatic compound substituted with one or more ether groups
07/10/2003WO2003055438A2 Crystalline form i of 2-methyl-4-(4-methyl-1-piperazinyl) 10h thieno [2,3-b][1,5]benzodiazepine
07/10/2003US20030130517 Useful as antiinflammatory drugs, particularly as remedies for rheumatoid arthritis
07/10/2003US20030130304 Preventive or therapeutic agents for gastric or esophageal regurgitation
07/10/2003US20030130271 1,3-Diheterocyclic metalloprotease inhibitors
07/10/2003US20030130270 Heterocyclic derivatives and their use as antithrombotic agents
07/10/2003US20030130257 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030129552 Color photothermography
07/10/2003US20030129191 Radiolabeled biotin and derivatives/conjugates bind hepatocyte receptors; anticancer agents; drug delivery
07/09/2003EP1325339A2 Method of assaying pyrrole-containing biological compounds
07/09/2003EP1325007A2 Hexahydropyrazino[1'2':1,6]-pyrido[3,4-b]indole-1,4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
07/09/2003EP0988306B1 3-substituted 3,4 dihydro-thieno 2, 3-d]pyrimidine derivatives and production and use of the same
07/09/2003CN1429215A 三唑衍生物 Triazole derivatives
07/09/2003CN1429210A Substituted thioacetamides
07/09/2003CN1428344A Method for preparing neutral polyethyidenedioxythiophene and its correspondent compound
07/09/2003CN1113894C Process for preparing intermediates of inhibitors of enkephalinase and angiotensin coverting enzyme and intermediates thereof
07/09/2003CN1113890C Heterocyclic metallocenes and polymerization catalysts
07/09/2003CN1113885C Process for producing beta-lactam derivs.
07/09/2003CN1113884C Process for producing hexahydrothiophene [3,4-d] imidazole-2,4-diones
07/08/2003US6589934 Methods of treatment of non insulin dependent diabetes mellitus, antagonists of the delayed rectifier potassium channel Kv2.1, methods of using and preparing the antagonists and assays for identifying such antagonist
07/08/2003US6589736 Photocleavable agents and conjugates for the detection and isolation of biomolecules
07/03/2003WO2003054053A1 New 3,4-alkylenedioxythiophene compounds and polymers thereof
07/03/2003WO2003053944A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003WO2003053446A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors
07/03/2003WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function
07/03/2003WO2003053331A2 Protease inhibitors
07/03/2003WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3
07/03/2003WO2003018548A3 Halogenated calixpyrroles, calixpyridinopyrroles and calixpyridines, and uses thereof
07/03/2003WO2002018389A3 Thienopyrimidine
07/03/2003US20030125322 Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2471098A1 Pancreatic lipase inhibitor compounds, their synthesis and use
07/03/2003CA2436850A1 Protease inhibitors
07/02/2003EP1323719A1 Thienopyrimidine compounds and salts thereof and process for the preparation of the same
07/02/2003EP1323711A1 Novel phenylalanine derivatives
07/02/2003EP1322651A1 Bicyclic heteroaromatic compounds
07/02/2003EP1322619A1 Isoquinolinone potassium channel inhibitors
07/02/2003EP1171444B1 Pyrido-thieno-diazepines, method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines
07/02/2003EP1016664B1 Fused thiophene compounds and medicinal use thereof
07/01/2003US6586603 Forming 4-(5-(4-chlorophenyl)-3-trifluoromethyl)-1H-pyrazol-1 -yl)benzenesulfonamide used as antiinflammatory agents; side effect reduction
07/01/2003US6586445 Racemic mixtures of 1,2,3,4-tetra hydro-1-(4-methoxyphenyl)-3 -(4-phenyl-1H-imidazol-2-yl)-9H- pyrido(3,4-b)indole, which bind to somatostatin receptors and block sodium channel modulators; antidiabetic, antiinflammatory agents; diarrhea
07/01/2003US6586441 Adenosine receptor ligands and their use in the treatment of disease
07/01/2003US6586422 Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno [d] azepine
06/2003
06/27/2003CA2415120A1 Process for the preparation of neutral polyethylenedioxythiophene, and corresponding polyethylenedioxythiophenes
06/26/2003WO2003051362A2 Polymorphs of clopidogrel hydrogensulfate
06/26/2003US20030120080 Such as (2S)-2-((4S)-4-(2,2-difluorovinyl)-2-oxopyrrolidinyl) butanamide; antiepileptic agents; anticonvulsants
06/26/2003US20030120066 Synthetic peptides